Cancers · 2011 · 91 citations · 72 references
MedicineCancer BiologyMolecular BiologyEpigeneticsMolecular OncologyTranscriptional RegulationCancer EpigeneticsEpigenetic AlterationsEpigenetic Regulation In CancerHistone ModificationsHormonal Cancer TherapyPromoter RegulationEpigenetic DeregulationEpigenetic Signaling PathwaysEpigenomic RegulationEstrogen Receptor SignalingEstrogen ReceptorsHistone Modifications At PromotersNeoplastic ProgressionTherapeutic Epigenetics
Estrogen receptor (ERα) signaling plays a key role in hormonal cancer progression. ERα is a ligand-dependent transcription factor that modulates gene transcription via recruitment to the target gene chromatin. Emerging evidence suggests that ERα signaling has the potential to contribute to epigenetic changes. Estrogen stimulation is shown to induce several histone modifications at the ERα target gene promoters including acetylation, phosphorylation and methylation via dynamic interactions with histone modifying enzymes. Deregulation of enzymes involved in the ERα-mediated epigenetic pathway could play a vital role in ERα driven neoplastic processes. Unlike genetic alterations, epigenetic changes are reversible, and hence offer novel therapeutic opportunities to reverse ERα driven epigenetic changes. In this review, we summarize current knowledge on mechanisms by which ERα signaling potentiates epigenetic changes in cancer cells via histone modifications.
72
Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
Yujiang Geno Shi, Yujiang Geno Shi, Fei Lan et al. · Cell · 2004 · 4K citations · Full text
Active genes are tri-methylated at K4 of histone H3
Helena Santos-Rosa, Robert Schneider, Andrew J. Bannister et al. · Nature · 2002 · 2.2K citations
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Yanming Wang, Joanna Wysocka, Joyce Sayegh et al. · Science · 2004 · 995 citations